CAS NO: | 204656-20-2 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Liraglutide is aglucagon-like peptide-1(GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus. | ||||||||||||||||
IC50& Target | GLP-1 receptor[1] | ||||||||||||||||
体外研究 (In Vitro) | Liraglutide binds to the same receptors as does the endogenous metabolic hormone GLP-1. Liraglutide is an injectable drug for the treatment of type 2 diabetes, also can be used to treat obesity in adults with some related comorbidity. Liraglutide activated AMPK/SREBP1 pathway in oxLDL-stimulated Raw264.7 cells[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 3751.26 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C172H265N43O51 | ||||||||||||||||
CAS 号 | 204656-20-2 | ||||||||||||||||
Sequence Shortening | HAEGTFTSDVSSYL-{N6-[N-(1-oxohexadecyl)-L-γ-Etamyl]-Glu}-GQAAKEFIAWLVRGRG | ||||||||||||||||
中文名称 | 利拉鲁肽 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 9.09 mg/mL(2.42 mM;ultrasonic and adjust pH to 3 with HCl) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |